<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000750029"><TermName>COPP-ABV regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma in children. It may be used with radiation therapy. COPP-ABV regimen includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, prednisone, doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, and vinblastine sulfate. Also called COPP-ABV.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000752681" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPP-ABV regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000752682" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen COPP-ABV&quot;" language="es" id="_4"/><SpanishTermName>régimen COPP-ABV</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin en los niños. Se puede usar con radioterapia.  El régimen COPP-ABV incluye los siguiente medicamentos: ciclofosfamida, sulfato de vincristina (Oncovin), clorhidrato de procarbazina, clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina y sulfato de vinblastina. También se llama COPP-ABV.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2013-06-19</DateFirstPublished></GlossaryTerm>
